Published in N Engl J Med on November 07, 1991
Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol (2012) 2.98
The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother (2009) 1.80
Randomised trials of STD treatment for HIV prevention: report of an international workshop. HIV/STD Trials Workshop Group. Genitourin Med (1997) 1.66
Antimicrobial susceptibilities of Neisseria gonorrhoeae strains representing five distinct resistance phenotypes. Antimicrob Agents Chemother (1994) 1.49
Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis (2015) 1.27
Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. Antimicrob Agents Chemother (1994) 1.25
Sexually transmitted diseases in the 1990s. N Engl J Med (1991) 0.96
The diagnosis and treatment of urethritis in developing countries. Genitourin Med (1994) 0.95
Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991. Antimicrob Agents Chemother (1995) 0.92
Antibiotic treatment of gonorrhoea--clinical evidence for choice. Genitourin Med (1996) 0.89
Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy. Clin Microbiol Rev (1993) 0.85
Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains. Antimicrob Agents Chemother (1996) 0.78
Gonorrhoea. BMJ Clin Evid (2007) 0.77
Gonorrhoea. BMJ Clin Evid (2011) 0.76
Gonorrhea: Treatment update for an increasingly resistant organism. Can Pharm J (Ott) (2015) 0.75
Gonorrhoea. BMJ Clin Evid (2014) 0.75
Management of gonococcal infection among adults and youth: New key recommendations. Can Fam Physician (2015) 0.75
Cefixime use in children: When and why. Can J Infect Dis (1995) 0.75
Real-Time PCR Targeting penA Mosaic XXXIV Type for Prediction of Extended-Spectrum Cephalosporins Susceptibility in Clinical Neisseria gonorrhoeae Isolates. Antimicrob Agents Chemother (2017) 0.75
A computerised data base for the diagnosis of rare dysmorphic syndromes. J Med Genet (1984) 8.10
Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis (1995) 5.94
Studies on the bacteremia of bacterial endocarditis. JAMA (1967) 5.00
Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med (1970) 4.93
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA (1999) 4.91
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med (1988) 4.81
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA (2001) 4.54
The physician's responsibility toward hopelessly ill patients. A second look. N Engl J Med (1989) 4.20
Parental monitoring: association with adolescents' risk behaviors. Pediatrics (2001) 4.15
Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. J Infect Dis (1994) 3.93
Quantitative bacteriology of the vaginal flora. J Infect Dis (1977) 3.81
Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med (1988) 3.71
Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis (2000) 3.60
Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50
Evaluation of ligase chain reaction for use with urine for identification of Neisseria gonorrhoeae in females attending a sexually transmitted disease clinic. J Clin Microbiol (1995) 3.47
Fifteen-month follow-up study of women infected with Chlamydia trachomatis. N Engl J Med (1979) 3.26
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol (1984) 3.15
The genital mycoplasmas (first of two parts). N Engl J Med (1980) 3.12
Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med (1984) 2.89
Nonculture tests for genital tract chlamydial infection. What does the package insert mean, and will it mean the same thing tomorrow? Sex Transm Dis (1992) 2.80
Partner type and condom use. AIDS (2000) 2.78
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 2. Results of the serological surveys in the study population--the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull World Health Organ (1969) 2.77
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med (1984) 2.71
Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA (1995) 2.71
Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs. J Clin Microbiol (1995) 2.62
Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS (1998) 2.53
The rapid test paradox: when fewer cases detected lead to more cases treated: a decision analysis of tests for Chlamydia trachomatis. Sex Transm Dis (1999) 2.52
Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population. J Clin Microbiol (1993) 2.35
Antigens of Treponema pallidum recognized by IgG and IgM antibodies during syphilis in humans. J Infect Dis (1985) 2.29
Epidemiology of gonorrhea: distribution and temporal changes in auxotype/serovar classes of Neisseria gonorrhoeae. Sex Transm Dis (1987) 2.27
Leukocyte bactericidal activity in chronic granulomatous disease: correlation of bacterial hydrogen peroxide production and susceptibility to intracellular killing. J Bacteriol (1969) 2.25
Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA (1983) 2.25
Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis). J Infect Dis (1977) 2.23
Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy. Am J Med (1969) 2.23
Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest (1977) 2.23
Gonococcal infections. Ann Intern Med (1985) 2.23
The genital mycoplasmas. N Engl J Med (1973) 2.21
Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures. J Clin Microbiol (1987) 2.21
Sexual behavior of college women in 1975, 1986, and 1989. N Engl J Med (1990) 2.18
Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. JAMA (1994) 2.18
Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health (1992) 2.16
Comparison of bacteriological methods for the isolation of group of B Streptococcus from vaginal cultures. J Clin Microbiol (1976) 2.14
Emotional, behavioral, and HIV risks associated with sexual abuse among adult homosexual and bisexual men. Child Abuse Negl (1994) 2.09
Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis (1983) 2.08
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA (1996) 2.07
Endemic cholera in rural East Pakistan. Am J Epidemiol (1969) 2.06
In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin. Antimicrob Agents Chemother (1976) 2.04
Enzyme immunoassay for diagnosis of gonorrhea. J Clin Microbiol (1984) 2.03
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Association of Streptococcus bovis bacteremia with bowel disease. J Clin Microbiol (1983) 2.01
Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: risk behavior, seroincidence, and willingness to participate. J Infect Dis (1996) 2.00
Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation. Bull World Health Organ (1969) 2.00
Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis (2000) 2.00
Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: high therapeutic success rates despite poor compliance. Sex Transm Dis (1999) 1.99
Microbiology of the vagina in children: normal and potentially pathogenic organisms. Pediatrics (1978) 1.98
Gonorrhea in the HIV era: a reversal in trends among men who have sex with men. Am J Public Health (2001) 1.94
Circumcision and STD in the United States: cross sectional and cohort analyses. Sex Transm Infect (2000) 1.94
Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol (1988) 1.92
The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity. J Clin Invest (1970) 1.91
Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis (1999) 1.90
Role of the vegetation in experimental Streptococcus viridans endocarditis. Infect Immun (1974) 1.89
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
The genital mycoplasmas (second of two parts). N Engl J Med (1980) 1.86
Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health (2000) 1.80
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis (1994) 1.78
Vaginal colonization with group B streptococcus: a study in college women. J Infect Dis (1977) 1.76
Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother (1977) 1.75
Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis (1997) 1.75
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Geographic variation among isolates of Trichomonas vaginalis: demonstration of antigenic heterogeneity by using monoclonal antibodies and the indirect immunofluorescence technique. J Infect Dis (1985) 1.74
Epidemiology of sexually transmitted diseases in rape victims. Rev Infect Dis (1989) 1.73
The effect of treating sexually transmitted diseases on the transmission of HIV in dually infected persons: a clinic-based estimate. Ad Hoc STD/HIV Transmission Group. Sex Transm Dis (2000) 1.72
Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis (1997) 1.69
Prevalence and persistence of Neisseria cinerea and other Neisseria spp. in adults. J Clin Microbiol (1988) 1.67
Bacterial vaginosis in lesbians: a sexually transmitted disease. Clin Infect Dis (1995) 1.65
Characterization of patients accepting and refusing routine, voluntary HIV antibody testing in public sexually transmitted disease clinics. Sex Transm Dis (1994) 1.63
Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group. Sex Transm Dis (1997) 1.61
Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection. J Infect Dis (1979) 1.60
Comparison of intradermal and subcutaneous routes of cholera vaccine administration. Lancet (1972) 1.60
Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis (1993) 1.60
Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens. J Clin Microbiol (1990) 1.59
Prospective study of maternal and infantile infection with Chlamydia trachomatis. Pediatrics (1979) 1.58
Sexual activity and vaginal colonization with genital mycoplasmas. JAMA (1972) 1.57
Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med (1986) 1.57
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med (1990) 1.55
Sustained bacteremia in patients with prosthetic cardiac valves. N Engl J Med (1972) 1.54
Effect of HIV posttest counseling on STD incidence. JAMA (1992) 1.53
Vulvar ulcer of unknown etiology in a human immunodeficiency virus-infected woman: response to treatment with zidovudine. Am J Obstet Gynecol (1990) 1.53
Comparison of bile and trypticase soy broth for isolation Salmonella from blood. Am J Clin Pathol (1966) 1.52
Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion. Sex Transm Dis (1993) 1.52
Natural serum bactericidal activity against Neisseria gonorrhoeae isolates from disseminated, locally invasive, and uncomplicated disease. J Immunol (1980) 1.52
Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex Transm Dis (1997) 1.51